Walleye Capital LLC Bristol Myers Squibb CO Call Options Transaction History

Walleye Capital LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $4.88 Million - $6.43 Million	121,300 Added 38.57%	435,800 $18.1 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $3.67 Million - $4.16 Million	-76,500 Reduced 19.57%	314,500 $17.1 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $12.1 Million - $14.4 Million	249,000 Added 175.35%	391,000 $20.1 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $7.28 Million - $8.14 Million	-125,800 Reduced 46.98%	142,000 $8.24 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $11.6 Million - $12.9 Million	182,300 Added 213.22%	267,800 $17.1 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $3.53 Million - $4 Million	53,700 Added 168.87%	85,500 $5.93 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $588,928 - $697,374	-8,600 Reduced 21.29%	31,800 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $5,252 - $3.1 Million	40,400 New	40,400 $2.87 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.57 Million - $2.29 Million	-33,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $6.53 Million - $8.51 Million	-132,600 Reduced 79.64%	33,900 $2.18 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $2.44 Million - $2.89 Million	57,000 Added 52.05%	166,500 $8.44 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $4.74 Million - $5.24 Million	106,300 Added 3321.88%	109,500 $4.97 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $144,384 - $172,160	3,200 New	3,200 $153,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.